Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Capital Expenditures (2025)

Mereo BioPharma (MREO) has disclosed Capital Expenditures for 1 consecutive years, with $20000.0 as the latest value for Q1 2025.

  • Quarterly Capital Expenditures changed N/A to $20000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $20000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $20000.0 for FY2025, N/A changed from the prior year.
  • Capital Expenditures for Q1 2025 was $20000.0 at Mereo BioPharma.
  • The five-year high for Capital Expenditures was $20000.0 in Q1 2025, with the low at $20000.0 in Q1 2025.